Smith-Magenis Syndrome Chromosome Region, Candidate 7-Like (SMCR7L) (N-Term) Peptide
Aperçu rapide pour Smith-Magenis Syndrome Chromosome Region, Candidate 7-Like (SMCR7L) (N-Term) Peptide (ABIN984128)
Antigène
Origine
Source
Application
-
-
Protein Region
- N-Term
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SMCR7L antibody (Catalog #: ARP49422_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SMCR7L (Smith-Magenis Syndrome Chromosome Region, Candidate 7-Like (SMCR7L))
-
Sujet
-
The specific function of this protein remains unknown.
Alias Symbols: FLJ20232, HSU79252, dJ1104E15.3, MID51, MIEF1
Protein Interaction Partner: MAGEA1
Protein Size: 463 -
Poids moléculaire
- 51 kDa
-
ID gène
- 54471
-
NCBI Accession
- NM_019008, NP_061881
-
UniProt
- Q9NQG6
Antigène
-